UFMylation safeguards human hepatocyte differentiation and liver homeostasis by regulating ribosome dissociation
Cell Reports · 2025-05 · 44 (5) · 115686
DOI: 10.1016/j.celrep.2025.115686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-05. Verfasst von Shuchun Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Pek…. Hauptthemen laut MEDLINE: Ribosomes, Hepatocytes, Cell Differentiation, Homeostasis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences, Peking Union Medical College.
Abstract (Originalsprache)
Ribosomal UFMylation contributes to ribosome heterogeneity and is associated with ribosome-associated quality control at the endoplasmic reticulum. However, the specific pathophysiological functions of ribosomal UFMylation remain unknown. In this study, we systematically demonstrate the significance of UFMylation in the differentiation and maturation of hepatocytes using human embryonic stem cell-derived hepatocyte-like cells and liver bud organoids as experimental platforms. We also develop a strategy to identify UFMylated substrates and confirm that RPL26 is a substrate in the liver. Additionally, we discover that mice with the Rpl26 c.395A>G (p.K132R) mutation are more susceptible to steatosis induced by a high-fat diet. Further investigations reveal a key role of CDK5RAP3 and RPL26 UFMylation in regulating ribosome dissociation. Our findings suggest that ribosome UFMylation serves as an important safeguard for liver development and homeostasis and may represent a potential therapeutic target for nonalcoholic fatty liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China; Department of Medica…
- State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
- State Key Laboratory of Medical Proteomics, Beijng Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drugs of Chinese Academy of Medi…
- Center for Stem Cell Biology and Regenerative Medicine, School of Medicine, Tsinghua University, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Meteorological Sciences
- Peking Union Medical College
- Chinese Academy of Sciences
Zitieren
APA
Yang, S., Wang, L., Gao, R., Li, Y., Zhang, D., Wang, C., Liu, G., Na, J., Xu, P., Wang, X., Jia, Y., & Huang, Y. (2025). UFMylation safeguards human hepatocyte differentiation and liver homeostasis by regulating ribosome dissociation. Cell Reports, 44(5), 115686. https://doi.org/10.1016/j.celrep.2025.115686
Vancouver
Yang S, Wang L, Gao R, Li Y, Zhang D, Wang C, et al. UFMylation safeguards human hepatocyte differentiation and liver homeostasis by regulating ribosome dissociation. Cell Reports. 2025;44(5):115686. doi:10.1016/j.celrep.2025.115686
BibTeX
@article{Yang2025,
author = {Yang, Shuchun and Wang, Li and Gao, Ran and Li, Yanchang and Zhang, Duo and Wang, Chenxi and Liu, Guang and Na, Jie and Xu, Ping and Wang, Xiaoyue and Jia, Yuyan and Huang, Yue},
title = {UFMylation safeguards human hepatocyte differentiation and liver homeostasis by regulating ribosome dissociation},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {5},
pages = {115686},
doi = {10.1016/j.celrep.2025.115686}
}
EUVIMED